Press release
Global Generic Injectables Market to Reach US$ 43 Billion by 2022
The global generic injectables market has experienced a significant growth over the past several years. This can be accredited to the government support to the manufacturers in the form of easy approvals and less stringent manufacturing procedures.Get sample report @ http://www.imarcgroup.com/request?type=report&id=804&flag=B
The latest report published by IMARC Group titled “Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” finds that the global generic injectables market exhibited a CAGR of around 9% during 2009-2016, reaching a value of more than US$ 23 Billion in 2016. Generic injectables are important for the treatment of various life threatening and chronic diseases. These drugs are also significantly cheaper than their branded counterparts with the same level of efficiency. As a result, they help in lowering the overall cost of treatment for both the healthcare providers and the patients. Besides, the generic injectable manufacturers enjoy considerably greater profit margins and lesser price erosions as compared to oral generic drugs owing to the low competition in the industry.
Highlights of the global generic injectables market:
Rising cases of chronic and lifestyle diseases remain the one of the major demand driving factors.
Oncology segment dominates the market, accounting for the majority of the total share.
North America holds more than a half of the global share, representing the largest market.
The generic injectables industry has been characterised by the presence of high entry barriers in the form of strict quality control regulations and a relatively complex manufacturing process. This has been the primary reason for the low competition in the industry, particularly in the US which is the largest market for generic injectables. However, the governments of various countries are supporting the manufacture of these drugs in the form of easy approvals and less stringent manufacturing procedures. These regulatory changes, coupled with the high profitability in the market, have encouraged a large number of pharmaceutical giants to enter it. Another major factor is the rising cases of chronic health problems on account of sedentary lifestyles and various environmental factors. This has created a huge demand for affordable pharmaceutical products. As a result of these factors, the global generic injectables market is projected to witness a strong growth over the next five years, reaching a value of US$ 43 Billion by 2022.
On the basis of therapeutic area, the market has been segmented as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular, etc. Among these, the oncology segment dominates the market, holding the majority of the market share. The market has also been analysed on the basis of distribution channels covering hospitals and retail pharmacy stores. Currently, hospitals account for the largest market share. Region-wise, North America represents the leading market, accounting for more than a half of the total share. The other major markets include Europe, Asia, Latin America, and Middle East and Africa. Some of the key players operating in the market include Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter.
Read full report with TOC @ http://www.imarcgroup.com/generic-injectables-market
The report by IMARC Group has examined the global generic injectables market on the basis of:
Therapeutic Area:
Oncology
Anaesthesia
Anti-infectives
Parenteral Nutrition
Cardiovascular
Distribution Channel:
Hospitals
Retail Pharmacy Stores
Region:
North America
Europe
Asia
Latin America
Middle East and Africa
Key Players:
Hospira (Pfizer)
Fresenius Kabi
Hikma
Sandoz (Novartis)
Sagent
Sanofi
Baxter
Browse related reports :
US Generic Injectables Market @ http://www.imarcgroup.com/us-generic-injectables-market
US Generic Drug Market @ http://www.imarcgroup.com/us-generics-market
About us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us
IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Generic Injectables Market to Reach US$ 43 Billion by 2022 here
News-ID: 709799 • Views: …
More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India seafood…

India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025:
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2.50 Billion
Market Size in 2033: USD 5.90 Billion
Market Growth Rate (CAGR) 2025-2033: 10.03%
How Big is the India Mutual Funds Industry?
The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033.
Request…

Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview:
The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC…

Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay.
IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…